Anti-human cytomegalovirus activity of constituents from Sasa albo-marginata (Kumazasa in Japan)

Antiviral Chemistry and Chemotherapy

Volumn 19, Issue 3, 2008, Pages 125-132

  Sakai, Asumi ^a   Watanabe, Kunitomo ^b   Koketsu, Mamoru ^b   Akuzawa, Kazuhiko ^a   Yamada, Rie ^a   Li, Zhuan ^a   Sadanari, Hidetaka ^a   Matsubara, Keiko ^a   Murayama, Tsugiya ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBENZALDEHYDE; BETA ACTIN; FLAVONE DERIVATIVE; PARA COUMARIC ACID; PLANT EXTRACT; SASA ALBO MARGINATA EXTRACT; TRICIN; UNCLASSIFIED DRUG; VANILLIN; VIRUS ANTIGEN;

ANTIVIRAL ACTIVITY; ARTICLE; BAMBUSA; DRUG STRUCTURE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN EMBRYO; JAPAN; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 56249130771     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020801900303     Document Type: Article

References (37)

1. Britt WJ. Cytomegalovirus, In Fields Virology, 3rd edn. Edited by BN Fields, DM Knipe & PM Howly. Philadelphia: Lippincott-Raven Publishers 1991; pp. 2493-2523.
2. Ho M. Virus infections after transplantation in man. Brief review. Arch Virol 1977; 55:1-24.
3. Meyers JD. Infection in bone marrow transplant recipients. Am J Med 1986; 81:27-38.
4. Sissons JG, Carmichael AJ. Clinical aspects and management of cytomegalovirus infection. J Infect 2002; 44:78-83.
5. Zaia JA. Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin Infect Dis 1993; 17:5392-5399.
6. Freitas VR, Fraser-Smith EB, Matthews TR. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Res 1989; 12:205-212.
7. Buerger I, Reefschlaeger J, Bender W, et al. A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. J Virol 2001; 75:9077-9086.
8. McSharry JJ, McDonough A, Olson B, Talarico C, Davis M, Biron KK. Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94. Clin Diagn Lab Immunol 2001; 8:1279-1281.
9. Shigeta S, Konno K, Baba M, Yokota T, De Clercq E. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. J Infect Dis 1991; 163:270-275.
10. Yukawa TA, Kurokawa M, Sato H, et al. Prophylactic treatment of cytomegalovirus infection with traditional herbs. Antiviral Res 1996; 32:63-70.
11. Sakai S, Saito G, Sugiyama J, Kamasuka T, Takeda S, Takano T. On the anticancer action of bamboo extract. J Antibiot B 1963; 16:387-391.
12. Shibata M, Fujii A, Yamaguchi R. Pharmacological studies on bamboo grass. IV. Toxicological and pharmacological effects of the extract (FIII) obtained from Sasa albomarginata Makino et Shibata (author's transl). Yakugaku Zasshi 1979; 99:663-668.
13. Shibata M, Kubo K, Onoda M. Pharmacological studies on bamboo grass. (2) Central depressant and antitoxic actions of a water-soluble fraction (folin) extracted from Sasa albomarginata Makino et Shibata. Folia Pharmacol Jpn 1976; 72:531-541.
14. Shibata M, Yamatake Y, Sakamoto M, Kanamori M, Takagi M, Okabe S. Pharmacological studies on bamboo grass (1): Acute toxicities, anti-inflammatory and antiulcerogenic activities of water-soluble fraction (Folin) extracted from Sasa albomarginata Makino et Shibata. Folia Pharmacol Jpn 1975; 71:481-490.
15. Kuboyama N, Fujii A, Tamura T. Antitumor activities of bamboo leaf extracts (BLE) and its lignin (BLL). Folia Pharmacol Jpn 1981; 77:579-596.
16. Jassim SA, Naji MA. Novel antiviral agents: a medical plant perspective. J Appl Microbiol 2003; 95:412-427.
17. Jacobs JP, Jones CM, Belle JP. Characteristics of a diploid cell designated MRC-5. Nature 1970; 227:168-173.
18. Furukawa T, Fioretti A, Plotkin S. Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication. J Virol 1973; 11:991-997.
19. Sasaki T, Okayama A, Eizuru Y, et al. Progressive retinitis-encephalitis due to ganciclovir- resistant cytomegalovirus associated with aplastic anemia. Jap Intern Med 1997; 36:375-379.
20. Harada K, Eizuru Y, Isashiki Y, Ihara S, Minamishima Y. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir. Arch Virol 1997; 142:215-225.
21. Wentworth BB, French L. Plaque assay of cytomegalovirus strain of human origin. Proc Soc Exp Biol Med 1970; 135:253-258.
22. Murayama T, Eizuru Y, Yamada R, et al. Anticytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eckl.& Zeyh.). Antivir Chem Chemother 2007; 18:133-139.
23. Murayama T, Mukaida N, Khabar KS, Matsushima K. Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. J Leukocyte Biol 1998; 64:62-67.
24. Scholz M, Doerr HW, Cinatl J. Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option? Antiviral Res 2001; 49:129-145.
25. Castillo JP, Kowalik TF. Human cytomegalovirus immediate early proteins and cell growth control. Gene 2002; 290:19-34.
26. Margolis MJ, Pajovic S, Wong EL, et al. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J Virol 1995; 69:7759-7767.
27. Taylor RT, Bresnahan WA. Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. J Virol 2006; 80:920-928.
28. Zhu H, Shen Y, Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 1995; 69:7960-7970.
29. Murayama T, Mukaida N, Sadanari H, et al. The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression. Biochem Biophys Res Comu 2000; 279:298-304.
30. Gawn JM, Greaves RF. Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol 2002; 76:4441-4455.
31. Marchini A, Liu H, Zhu H. Human cytomegalovirus with IE-2(UL122) detected fails to express early lytic genes. J Virol 2001; 75:1870-1878.
32. Zhen H, Fang F, Ye D, et al. Experimental study on the action of allitridin against human cytomegalovirus in vitro: inhibitory effects on immediate-early genes. Antiviral Res 2006; 72:68-74.
33. Min mice. Mol Cancer Ther 2005; 4:1287-1292.
34. Moscatelli V, Hnatyszyn O, Acevedo C, Megias J, Alcaraz MJ, Ferrana G. Flavonoids from Artemisia copa with anti-inflammatory activity. Planta Med 2006; 72:72-74.
35. Jeong YH, Chung SY, Han A-R, et al. P-glycoprotein inhibitory activity of two phenolic compounds, (-)-syringaresionol and tricin from Sasa borealis. Chem Biodiv 2007; 4:12-16.
36. Duarte-Almeida JM, Negri G, Salatino A, de Carvalho JE, Lajolo FM. Antiproliferative and antioxidant activities of a tricin acylated glycoside from sugarcane (Saccharum officinarum) juice. Phytochem 2007; 68:1165-1171.
37. Li H, Zhou C, Pan Y, et al. Evaluation of antiviral activity of compounds isolated from Ranunculus sieboldii and Ranunculus sceleratus. Planta Med 2005; 71:1128-1133.